Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.540
0.00 (0.00%)
At close: May 22, 2026, 4:00 PM EDT
2.500
-0.040 (-1.57%)
After-hours: May 22, 2026, 7:55 PM EDT
Nautilus Biotechnology Employees
Nautilus Biotechnology had 127 employees as of March 31, 2026. The number of employees decreased by 3 or -2.31% since the number was last reported on December 31, 2025.
Employees
127
Change
-3
Growth
-2.31%
Revenue / Employee
n/a
Profits / Employee
-$449,488
Market Cap
322.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 127 | -3 | -2.31% |
| Dec 31, 2025 | 130 | -25 | -16.13% |
| Dec 31, 2024 | 155 | -12 | -7.19% |
| Dec 31, 2023 | 167 | 33 | 24.63% |
| Dec 31, 2022 | 134 | 21 | 18.58% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Abeona Therapeutics | 226 |
| Invivyd | 122 |
| Neumora Therapeutics | 96 |
| Lineage Cell Therapeutics | 77 |
| Atea Pharmaceuticals | 55 |
| Immuneering | 53 |
| Surrozen | 44 |
NAUT News
- 26 days ago - Nautilus Biotechnology Earnings Call Transcript: Q1 2026 - Transcripts
- 26 days ago - Nautilus Biotechnology Earnings release: Q1 2026 - Filings
- 26 days ago - Nautilus Biotechnology Quarterly report: Q1 2026 - Filings
- 26 days ago - Nautilus Biotechnology Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 26 days ago - Nautilus Biotechnology Proxy statement: Proxy filing - Filings
- 26 days ago - Nautilus Biotechnology Proxy statement: Proxy filing - Filings
- 2 months ago - Nautilus Biotechnology Transcript: Investor Summit Virtual Conference - Transcripts
- 2 months ago - Nautilus announces first customer of its Iterative Mapping Early Access Program - TheFly